Children's Hospital of Orange County (CHOC) has made a commitment to both basic science and clinical research in an ongoing effort to unravel the complex underpinnings of diseases that affect children. This commitment keeps CHOC at the leading edge of technology, meaning children seen at CHOC benefit from the latest in scientific thinking with access to the most up-to-date treatment options. Research laboratories at CHOC support a variety of basic science, translational, and clinical research studies.
- Institutional Review Boards
CHOC currently has three Institutional Review Boards (IRBs)
- Research Administration
CHOC’s Research Administration office is a valuable resource for the CHOC community, providing expertise and highly specialized services in the important area of research management.
- Research Faculty
Information about the CHOC Children's Research Institute faculty.
- Proposal Preparation
Information you need for proposal preparation.
Dr. Phil Schwartz, Director of National Human Neural Stem Cell Research
Phil Schwartz, PhD, speaks about using stem cell research to understand the disease of autism.
Genomic Cancer Research: Dr. Sender, CHOC Children's
In this segment of American Health Journal, Dr. Leonard Sender, Medical Director of Hyundai Cancer Insititute at CHOC Children's, explains genomic cancer research and how identifying the specific medicines that work on a child's disease is a challenge.
Autism Research: Dr. Schwartz, CHOC Children's
In this segment of American Health Journal, Dr. Phil Schwartz, CHOC Children's, explains how autism is currently is being diagnosed and how new new research may lead to diagnosing the disorder with a simple blood test.
Genomic Cancer Research: Dr. Sender - No Place Like CHOC
Leonard Sender M.D., Medical Director of the Hyundai Cancer Institute at CHOC Children's, talks about clinical trials for cancer patients.
Dr. Diane Nugent, Medical Director, Hematology
Dr. Diane Nugent reveals that CHOC is able to launch tecnology not available anywhere else in the United states for monitoring sick children.
New Innovation in the AYA Cancer Movement: The Future Is Here
January 15, 2014
SAYAO held their first annual conference at the University of California, Irvine (UC Irvine), in partnership with the Hyundai Cancer Institute at the Children's Hospital of Orange County (CHOC Children's).
Advances in the Young Adult Cancer Movement: Why Sayao Is a Big Deal
December 16, 2013
SAYAO was envisioned and developed under the leadership of Dr. Leonard Sender, a pediatric and adult Hematologist/Oncologist.
The Future of the AYA Cancer Movement: A Chat With Dr. Leonard Sender
December 03, 2013
Dr. Sender is regarded as one of the leading advocacy pioneers of the adolescent and young adult (AYA) oncology movement
Articles From the Blog:
Autism and Stem Cell Research: Past and Future
Fri, 31 Jan 2014 18:00:07 GMT
Scientists and researchers at the CHOC Children’s Research Institute continue to study Autism Spectrum Disorders (ASDs) in an effort to find the causes and develop effective treatments for these perplexing and mysterious disorders. In one of CHOC’s research labs, Dr. Philip Schwartz and his team, including Drs. David Brick and Omar Khalid, use stem cells
CHOC Using Stem Cells To Study Impact Of Autism
Wed, 01 Sep 2010 02:35:39 GMT
Last year, CHOC Children’s Research Institute received a National Institutes of Health (NIH) Research Grant to generate, investigate, and store neural stem cells derived from skin cells, donated by children with autism. The program is designed to provide an important new tool for studying the impact of autism on the developing brain. Check out what
Why Research Matters
Sat, 21 Aug 2010 05:51:19 GMT
Watch as Diane Nugent, MD, tells us how the research happening at CHOC Children’s is changing screening and treatment for childhood disease. And not just in Orange County–across the country. Learn more about the CHOC Children’s Research Institute.
CHOC Research Institute Makes a Mark
Wed, 11 Aug 2010 07:25:17 GMT
CHOC Research Institute Associate Ryan Roberts is working with a team of scientists to identify specific genetic markers for Sickle Cell Disease and Thalassemia . By carefully studying the genetic origins of pediatric disease, he is helping to pioneer new screenings and treatments for red cell abnormalities. To learn more about The CHOC Research Institute,
Our Research Institute is REALLY Cool
Sat, 07 Aug 2010 05:56:40 GMT
Watch as the Director of CHOC Research Institute Brent Dethlefs shows off some of the “cool” equipment we’ve got in our state-of-the-art research labs here at the hospital. Scientists at the CHOC Research Institute use cryogenic freezers to store donated cord blood and bone marrow to be used for transplants in patients with oncology or
Articles From the CHOC Docs Blog:
Dr. Philip Schwartz Discusses Autism Research
Thu, 27 Feb 2014 10:00:12 GMT
Researchers are studying autism, a brain disease, by turning skin cells into brain cells through genetic manipulation, Philip Schwartz, Ph.D., a senior scientist at CHOC Children’s Research Institute, tells “American Health Journal.” Scientists are using these cells with a goal to develop drug therapies for autism, as well as a diagnostic tool for the disorder, […]
New Technique Reduces Post-Surgery Pain in Children
Mon, 16 Dec 2013 20:32:15 GMT
CHOC Children’s researchers have identified a new technique that significantly decreases pain and the need for pain medication in children following high-risk urology surgeries, a finding that was recently published in the “Journal of Pediatric Urology.” “While pain management is a fundamental part of pediatric surgical recovery and care for pediatric patients, current options involve […]
The post New Technique Reduces Post-Surgery Pain in Children appeared first on CHOC Docs Blog.
Curiosity Drives Infectious Diseases Research
Thu, 20 Sep 2012 23:39:24 GMT
A CHOC Children’s investigator-initiated trial into neonates with necrotizing enterocolitis (NEC) has discovered key microbial and survival differences in patients who develop blood stream infections. These findings may help explain why premature infants with intestinal pathology experience more complications and higher mortality rates. CHOC Infectious Diseases Medical Director Antonio Arrieta, M.D., and his team have […]